Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study
Las empresas, en general, estn intentando incluir fibra y protena en sus comidas, ya que esta es una de las preocupaciones que muchos usuarios y exusuarios del frmaco GLP-1 necesitan abordar
Researchers who treat MT-1 as a flexible cosmetic compound rather than a precision tool will consistently fail to replicate published results, not because the peptide doesn't work, but because the protocol wasn't followed with the rigour the compound requires
Tkc I, Raz I
Fremlin Dekyi, MD, to support clinical accuracy and patient-friendly education about BMI requirements for GLP-1 weight loss treatment
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomized controlled trial